ARTESp shows 62.5% positive clinical outcome after 90 days

The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischemic stroke. This was recently proven by four randomized controlled trials in patients with a proximal large vessel occlusion. The ARTESp study, recently published by Dr. Sascha Prothmann et al., mirrors and reinforces the findings of the above mentioned trials. ARTESp is a prospective, multicenter, single-arm Post Market Clinical Follow-up study in which the efficacy, the safety and the long-term outcomes of mechanical thrombectomy using the pREset® Thrombectomy Device were evaluated.

continue reading

Upcoming Events

Subscribe

to our email news

(max. one email per month)

Hemorrhagic Stroke Treatment

Flow Diverter

Bifurcation Aneurysm Treatment

Ischemic Stroke Treatment

Thrombectomy Device

PTA Balloon

     

Contact

phenox GmbH
Lise-Meitner-Allee 31
D-44801 Bochum

T +49 (0) 234-36 919-0
F +49 (0) 234-36 919-19

info@remove-this.phenox.info
www.phenox.net